Assisting Community-Based Oncologists and Surgeons in Making Treatment Decisions for Patients with ER-Positive, HER2-Negative Early Breast Cancer


Assisting Community-Based Oncologists and Surgeons in Making Treatment Decisions for Patients with ER-Positive, HER2-Negative Early Breast Cancer
Video proceedings from a roundtable discussion with Drs Harold J Burstein and Tari King featuring discussion of a comprehensive case-based survey focused on decision-making for patients with ER-positive, HER2-negative early breast cancer, actual patient cases, relevant data sets and ongoing clinical trials.
2.25 AMA PRA Category 1 Credits
To complete the Post-test and Educational Assessment and Credit Form, click here. A statement of CME credit will be issued for scores of 80% or better. Your statement of credit will be mailed to you within 3 weeks or may be printed online.

Genomic assays in the adjuvant setting

Neoadjuvant therapy and the use of genomic assays

Genomic assays and the decision to continue endocrine therapy beyond 5 years